Production (Stage)
Exelixis, Inc.
EXEL
$41.59
-$0.19-0.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.00% | 5.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.00% | 5.04% | |||
| Cost of Revenue | -3.97% | 15.22% | |||
| Gross Profit | -1.92% | 4.71% | |||
| SG&A Expenses | 2.13% | 20.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.61% | 14.67% | |||
| Operating Income | 14.31% | -12.98% | |||
| Income Before Tax | 11.32% | 19.40% | |||
| Income Tax Expenses | 2.59% | 22.10% | |||
| Earnings from Continuing Operations | 14.12% | 18.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.12% | 18.55% | |||
| EBIT | 14.31% | -12.98% | |||
| EBITDA | 13.50% | -12.39% | |||
| EPS Basic | 16.46% | 19.03% | |||
| Normalized Basic EPS | 13.46% | -10.07% | |||
| EPS Diluted | 14.46% | 20.13% | |||
| Normalized Diluted EPS | 13.25% | -11.04% | |||
| Average Basic Shares Outstanding | -2.01% | -0.38% | |||
| Average Diluted Shares Outstanding | -1.83% | 0.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||